The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-[4-(4-Acetyl-piperazin-1-yl)-2-fluoro-phenoxymethyl]-7-(2-cyclohexyl-ethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile ID: ALA494517
PubChem CID: 25023785
Max Phase: Preclinical
Molecular Formula: C28H33FN6O2
Molecular Weight: 504.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N1CCN(c2ccc(OCc3cc4cnc(C#N)nc4n3CCC3CCCCC3)c(F)c2)CC1
Standard InChI: InChI=1S/C28H33FN6O2/c1-20(36)33-11-13-34(14-12-33)23-7-8-26(25(29)16-23)37-19-24-15-22-18-31-27(17-30)32-28(22)35(24)10-9-21-5-3-2-4-6-21/h7-8,15-16,18,21H,2-6,9-14,19H2,1H3
Standard InChI Key: RKKQUNNKTWJTLY-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
19.0331 -1.1569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7495 -0.7435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7466 0.0870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0313 0.4961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3182 -0.7440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3149 0.0803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5299 0.3319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0480 -0.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5353 -1.0018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2230 -0.3403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8076 0.3724 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4646 -1.1549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1750 -1.5667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2836 -1.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4773 -1.9623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2255 -2.7479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9826 0.3691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5693 1.0823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7451 1.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3347 0.3626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7546 -0.3525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5774 -0.3460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5072 0.3564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0921 1.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2707 1.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8585 0.3531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2733 -0.3609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1010 -0.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0335 0.3518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6198 1.0656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6221 -0.3634 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4200 -2.9199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1675 -3.7016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7191 -4.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5267 -4.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7827 -3.3554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9800 1.7979 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17 18 2 0
8 9 1 0
18 19 1 0
9 5 1 0
19 20 2 0
4 6 1 0
20 21 1 0
8 10 1 0
21 22 2 0
22 17 1 0
23 24 1 0
5 6 2 0
10 11 1 0
1 2 2 0
2 12 1 0
5 1 1 0
12 13 3 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
20 23 1 0
2 3 1 0
26 29 1 0
9 14 1 0
29 30 1 0
29 31 2 0
16 32 1 0
14 15 1 0
3 4 2 0
15 16 1 0
6 7 1 0
11 17 1 0
16 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
7 8 2 0
18 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 504.61Molecular Weight (Monoisotopic): 504.2649AlogP: 4.66#Rotatable Bonds: 7Polar Surface Area: 87.28Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.34CX LogP: 4.56CX LogD: 4.56Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.47Np Likeness Score: -1.26
References 1. Irie O, Kosaka T, Ehara T, Yokokawa F, Kanazawa T, Hirao H, Iwasaki A, Sakaki J, Teno N, Hitomi Y, Iwasaki G, Fukaya H, Nonomura K, Tanabe K, Koizumi S, Uchiyama N, Bevan SJ, Malcangio M, Gentry C, Fox AJ, Yaqoob M, Culshaw AJ, Allan Hallett.. (2008) Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain., 51 (18): [PMID:18754655 ] [10.1021/jm800839j ]